408 related articles for article (PubMed ID: 24054518)
1. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
[TBL] [Abstract][Full Text] [Related]
2. Comparing the broad socio-cognitive profile of youth with Williams syndrome and 22q11.2 deletion syndrome.
Weisman O; Feldman R; Burg-Malki M; Keren M; Geva R; Diesendruck G; Gothelf D
J Intellect Disabil Res; 2017 Dec; 61(12):1083-1093. PubMed ID: 28990288
[TBL] [Abstract][Full Text] [Related]
3. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
5. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
6. Mother-Child Interaction as a Window to a Unique Social Phenotype in 22q11.2 Deletion Syndrome and in Williams Syndrome.
Weisman O; Feldman R; Burg-Malki M; Keren M; Geva R; Diesendruck G; Gothelf D
J Autism Dev Disord; 2015 Aug; 45(8):2567-77. PubMed ID: 25791124
[TBL] [Abstract][Full Text] [Related]
7. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
8. Bridging the gene-behavior divide through neuroimaging deletion syndromes: Velocardiofacial (22q11.2 Deletion) and Williams (7q11.23 Deletion) syndromes.
Eisenberg DP; Jabbi M; Berman KF
Neuroimage; 2010 Nov; 53(3):857-69. PubMed ID: 20206275
[TBL] [Abstract][Full Text] [Related]
9. Working Memory Impairments in Chromosome 22q11.2 Deletion Syndrome: The Roles of Anxiety and Stress Physiology.
Sanders AF; Hobbs DA; Stephenson DD; Laird RD; Beaton EA
J Autism Dev Disord; 2017 Apr; 47(4):992-1005. PubMed ID: 28083777
[TBL] [Abstract][Full Text] [Related]
10. Childhood cognitive development in 22q11.2 deletion syndrome: case-control study.
Chawner SJRA; Doherty JL; Moss H; Niarchou M; Walters JTR; Owen MJ; van den Bree MBM
Br J Psychiatry; 2017 Oct; 211(4):223-230. PubMed ID: 28882829
[No Abstract] [Full Text] [Related]
11. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
[TBL] [Abstract][Full Text] [Related]
12. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
[TBL] [Abstract][Full Text] [Related]
13. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
14. Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome.
Schonherz Y; Davidov M; Knafo A; Zilkha H; Shoval G; Zalsman G; Frisch A; Weizman A; Gothelf D
J Neurodev Disord; 2014 Feb; 6(1):3. PubMed ID: 24517288
[TBL] [Abstract][Full Text] [Related]
15. Developmental trajectories in 22q11.2 deletion.
Swillen A; McDonald-McGinn D
Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):172-81. PubMed ID: 25989227
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.
Tang KL; Antshel KM; Fremont WP; Kates WR
J Dev Behav Pediatr; 2015 Oct; 36(8):639-50. PubMed ID: 26372046
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
[TBL] [Abstract][Full Text] [Related]
18. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
[TBL] [Abstract][Full Text] [Related]
20. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
